FDA Allows Marketing of First WSI System for Digital Pathology

News   Apr 18, 2017 | Original story from FDA

 
FDA Allows Marketing of First WSI System for Digital Pathology
 
 
 

RELATED ARTICLES

UnitedHealthcare Establishes Long-Term Strategic Partnership with Quest Diagnostics

News

Partnership will include broad range of value-based programs, rewarding high-quality, easily accessible laboratory services at the best value and real-time data sharing to drive more personalized care support.

READ MORE

Shuwen Biotech and Bliss Biopharmaceutical Partner on Companion Diagnostics for Cancer Drugs

News

Under the agreement, Shuwen will develop companion diagnostics for Bliss’ oncology drug candidates. Shuwen also commits to provide testing services in its CAP-certified central labs for BlissBio’ clinical trials. The terms of the collaboration are undisclosed.

READ MORE

WHO Creates Essential Diagnostics List

News

WHO has published its first Essential Diagnostics List, a catalogue of the tests needed to diagnose the most common conditions as well as a number of global priority diseases.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy